Ablynx NV is formerly owned by Sofinnova Partners, through Sofinnova Capital VI, since 2008.

When did Sofinnova Partners acquire Ablynx NV?

Sofinnova Partners acquired Ablynx NV in 2008 and exited after 10 years.

Has Ablynx NV been sold?

Yes. Ablynx NV was exited in 2018 via Trade Sale.

Home/Companies/Biotech/Ablynx NV

Ablynx NV

Biotech·

Belgium·Exited 2018·Held 10yr

Ablynx NV is a healthcare / biotech company, headquartered in Belgium.

Entry

2008

Hold

10yr

Exit

2018

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQBelgium

SectorHealthcare / Biotech

Belgian biotech pioneering Nanobody-based therapeutics for inflammation, haematology and oncology, acquired by Sanofi in 2018. Acquired by…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

Omthera Pharmaceuticals

Exited 2013

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings